临床肾脏病理学
上QQ阅读APP看本书,新人免费读10天
设备和账号都新为新人

参考文献

[1]FOGO A B: Causes and pathogenesis of focal segmental glomerulosclerosis [J]. Nat Rev Nephrol, 2015, 11(2): 76-87.

[2]MIRIOGLU S, CALISKAN Y, OZLUK Y, et al. Co-deposition of IgM and C3 may indicate unfavorable renal outcomes in adult patients with primary focal segmental glomerulosclerosis [J]. Kidney Blood Press Res, 2019, 44 (5): 961-972.

[3]LIM B J, YANG J W, DO W S, et al. Pathogenesis of Focal Segmental Glomerulosclerosis [J]. J Pathol Transl Med, 2016, 50 (6): 405-410.

[4]STOKES M B, D′AGATI V D. Morphologic variants of focal segmental glomerulosclerosis and their signif icance [J]. Adv Chronic Kidney Dis, 2014, 21 (5): 400-7.

[5]KIENZL-WAGNER K, WALDEGGER S, SCHNEEBERGER S, et al. Disease recurrence-the Sword of Damocles in kidney transplantation for primary focal segmental glomerulosclerosis [J]. Front Immunol, 2019,10: 1669.

[6]RICHARD J, FEEHALLY J J, FLOEGE J, et al. Comprehensive Clinical Nephrology [M]. 5th ed. Elsevier, 2015: 222-228.

[7]COLAVITA L, SALPIETRO C, CUPPARI C. Nephrotic syndrome: immunological mechanisms [J]. J Biol Regul Homeost Agents, 2019, 33 (5 Suppl. 1): 13-18.

[8]COLVIN R B, CHANG A, GAUT J P, et al. Diagnostic Pathology: Kidney Diseases [M]. 2nd ed. Elsevier, 2016: 60-68.

[9]SADOWSKI C E, LOVRIC S, ASHRAF S, et al: A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome [J]. J Am SocNephrol, 2015, 26(6): 1279-1289.

[10]Kidney Disease: Improving Global Outcomes (KDIGO)Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis [J]. Kidney Int Suppl, 2012, 2: 181-185.

[11]ROVIN B H, CASTER D J, CATTRAN D C, et al. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference [J]. Kidney Int, 2019, 95 (2): 281-295.

[12]KIM K, SON H E, RYU J Y, et al. C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics [J]. PLoS One,2019, 14 (4): e0215217.

[13]Kidney Disease: Improving Global Outcomes (KDIGO)Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis [J]. Kidney Int Suppl, 2020: 190.